Photo taken from Rahul Banerjee/X
May 21, 2024, 15:48
Cancer Network – A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Cancer Network, on X:
“So much fun speaking with Saad Z. Usmani, Yi Lin, Doris Hansen about CAR-T in MMsm – and the ‘CAR-eligible’ vs ineligible pathways of the future. Although if our shirt colors are any indicator, for an RCT of CAR-T vs ‘investigator’s choice’ we’d all choose the same thing. ”
Quoting Cancer Network‘s post:
“A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy, highlighting BCMA as a target and treatment administration practices.”
Source: Rahul Banerjee/X and Cancer Network/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 15, 2024, 21:37
Nov 15, 2024, 21:26
Nov 15, 2024, 21:09
Nov 15, 2024, 21:05
Nov 15, 2024, 21:03
Nov 15, 2024, 21:02
Nov 15, 2024, 20:28
Nov 15, 2024, 19:31
Nov 15, 2024, 17:47
Nov 15, 2024, 17:45